Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.17% |
| Dec 31, 2025 | 0.26% |
| Sep 30, 2025 | 6.46% |
| Jun 30, 2025 | 0.66% |
| Mar 31, 2025 | 0.08% |
| Dec 31, 2024 | 5.56% |
| Sep 30, 2024 | 32.55% |
| Jun 30, 2024 | -58.79% |
| Mar 31, 2024 | 32.10% |
| Dec 31, 2023 | -5.70% |
| Sep 30, 2023 | 27.17% |
| Jun 30, 2023 | 28.67% |
| Mar 31, 2023 | 28.92% |
| Dec 31, 2022 | 36.51% |
| Sep 30, 2022 | 41.23% |
| Jun 30, 2022 | 44.38% |
| Mar 31, 2022 | 29.19% |
| Dec 31, 2021 | 47.05% |
| Sep 30, 2021 | 69.82% |
| Jun 30, 2021 | -47.10% |
| Mar 31, 2021 | 128.90% |
| Dec 31, 2020 | 75.96% |
| Sep 30, 2020 | 75.45% |
| Jun 30, 2020 | 62.75% |
| Mar 31, 2020 | 41.49% |
| Dec 31, 2019 | 34.81% |
| Sep 30, 2019 | 42.23% |
| Jun 30, 2019 | 41.26% |
| Mar 31, 2019 | 30.93% |
| Dec 31, 2018 | 73.94% |
| Sep 30, 2018 | 97.16% |
| Jun 30, 2018 | 222.53% |
| Mar 31, 2018 | 42.33% |
| Dec 31, 2017 | 41.18% |
| Sep 30, 2017 | 9.93% |
| Jun 30, 2017 | 8.94% |
| Mar 31, 2017 | 146.56% |
| Dec 31, 2016 | -22.07% |
| Sep 30, 2016 | 8.89% |